Tanujaa Suriyanarayanan, Lye Siang Lee, Sharon Hong Yu Han, Jianhong Ching, Chaminda J. Seneviratne
{"title":"用靶向代谢组学分析方法揭示粪肠球菌临床分离物的生物膜形成途径。","authors":"Tanujaa Suriyanarayanan, Lye Siang Lee, Sharon Hong Yu Han, Jianhong Ching, Chaminda J. Seneviratne","doi":"10.1111/iej.14110","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>(i) To characterize <i>Enterococcus faecalis</i> biofilm formation pathways by semi-targeted metabolomics and targeted nitrogen panel analysis of strong (Ef63) and weak (Ef 64) biofilm forming <i>E. faecalis</i> clinical isolates and (ii) to validate the identified metabolic markers using targeted inhibitors.</p>\n </section>\n \n <section>\n \n <h3> Methodology</h3>\n \n <p>Previous proteomics profiling of <i>E. faecalis</i> clinical isolates with strong and weak biofilm formation revealed that differences in metabolic activity levels of small molecule, nucleotide and nitrogen compound metabolic processes and biosynthetic pathways, cofactor metabolic process, cellular amino acid and derivative metabolic process and lyase activity were associated with differences in biofilm formation. Hence, semi-targeted analysis of Ef 63, Ef 64 and ATC control strain Ef 29212 was performed by selecting metabolites that were part of both the previously identified pathways and a curated library with confirmed physical and chemical identity, followed by confirmatory targeted nitrogen panel analysis. Significantly regulated metabolites (<i>p</i> < .05) were selected based on fold change cut-offs of 1.2 and 0.8 for upregulation and downregulation, respectively, and subjected to pathway enrichment analysis. The identified metabolites and pathways were validated by minimum biofilm inhibitory concentration (MBIC) and colony forming unit (CFU) assays with targeted inhibitors.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Metabolomics analysis showed upregulation of betaine, hypoxanthine, glycerophosphorylcholine, tyrosine, inosine, allantoin and citrulline in Ef 63 w.r.t Ef 64 and Ef 29212, and thesemetabolites mapped to purinemetabolism, urea cycle and aspartate metabolism pathways. MBIC and CFU assays using compounds against selected metabolites and metabolic pathways, namely glutathione against hypoxanthine and hydroxylamine against aspartate metabolism showed inhibitory effects against <i>E. faecalis</i> biofilm formation.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The study demonstrated the importance of oxidative stress inducers such as hypoxanthine and aspartate metabolism pathway in <i>E. faecalis</i> biofilm formation. Targeted therapeutics against these metabolic markers can reduce the healthcare burden associated with <i>E. faecalis</i> infections.</p>\n </section>\n </div>","PeriodicalId":13724,"journal":{"name":"International endodontic journal","volume":null,"pages":null},"PeriodicalIF":5.4000,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Targeted metabolomics analysis approach to unravel the biofilm formation pathways of Enterococcus faecalis clinical isolates\",\"authors\":\"Tanujaa Suriyanarayanan, Lye Siang Lee, Sharon Hong Yu Han, Jianhong Ching, Chaminda J. Seneviratne\",\"doi\":\"10.1111/iej.14110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>(i) To characterize <i>Enterococcus faecalis</i> biofilm formation pathways by semi-targeted metabolomics and targeted nitrogen panel analysis of strong (Ef63) and weak (Ef 64) biofilm forming <i>E. faecalis</i> clinical isolates and (ii) to validate the identified metabolic markers using targeted inhibitors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methodology</h3>\\n \\n <p>Previous proteomics profiling of <i>E. faecalis</i> clinical isolates with strong and weak biofilm formation revealed that differences in metabolic activity levels of small molecule, nucleotide and nitrogen compound metabolic processes and biosynthetic pathways, cofactor metabolic process, cellular amino acid and derivative metabolic process and lyase activity were associated with differences in biofilm formation. Hence, semi-targeted analysis of Ef 63, Ef 64 and ATC control strain Ef 29212 was performed by selecting metabolites that were part of both the previously identified pathways and a curated library with confirmed physical and chemical identity, followed by confirmatory targeted nitrogen panel analysis. Significantly regulated metabolites (<i>p</i> < .05) were selected based on fold change cut-offs of 1.2 and 0.8 for upregulation and downregulation, respectively, and subjected to pathway enrichment analysis. The identified metabolites and pathways were validated by minimum biofilm inhibitory concentration (MBIC) and colony forming unit (CFU) assays with targeted inhibitors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Metabolomics analysis showed upregulation of betaine, hypoxanthine, glycerophosphorylcholine, tyrosine, inosine, allantoin and citrulline in Ef 63 w.r.t Ef 64 and Ef 29212, and thesemetabolites mapped to purinemetabolism, urea cycle and aspartate metabolism pathways. MBIC and CFU assays using compounds against selected metabolites and metabolic pathways, namely glutathione against hypoxanthine and hydroxylamine against aspartate metabolism showed inhibitory effects against <i>E. faecalis</i> biofilm formation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The study demonstrated the importance of oxidative stress inducers such as hypoxanthine and aspartate metabolism pathway in <i>E. faecalis</i> biofilm formation. Targeted therapeutics against these metabolic markers can reduce the healthcare burden associated with <i>E. faecalis</i> infections.</p>\\n </section>\\n </div>\",\"PeriodicalId\":13724,\"journal\":{\"name\":\"International endodontic journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2024-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International endodontic journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/iej.14110\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International endodontic journal","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/iej.14110","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
目的:(i) 通过对强(Ef63)和弱(Ef64)生物膜形成的粪肠球菌临床分离株进行半靶向代谢组学和靶向氮面板分析,确定粪肠球菌生物膜形成途径的特征;(ii) 使用靶向抑制剂验证已确定的代谢标记物:之前对具有强生物膜形成能力和弱生物膜形成能力的粪大肠杆菌临床分离株进行的蛋白质组学分析表明,小分子、核苷酸和氮化合物代谢过程和生物合成途径、辅助因子代谢过程、细胞氨基酸和衍生物代谢过程以及裂解酶活性水平的差异与生物膜形成的差异有关。因此,对 Ef 63、Ef 64 和 ATC 对照菌株 Ef 29212 进行了半靶向分析,选择了既属于先前确定的途径又属于已确认物理和化学特性的策划文库的代谢物,然后进行了确认性靶向氮小组分析。受显著调控的代谢物(p 结果:代谢组学分析表明,与 Ef 64 和 Ef 29212 相比,Ef 63 中的甜菜碱、次黄嘌呤、甘油磷酸胆碱、酪氨酸、肌苷、尿囊素和瓜氨酸出现上调,这些代谢物与嘌呤代谢、尿素循环和天冬氨酸代谢途径相关。利用针对选定代谢物和代谢途径的化合物(即针对次黄嘌呤代谢的谷胱甘肽和针对天冬氨酸代谢的羟胺)进行的 MBIC 和 CFU 检测显示,这些化合物对粪肠杆菌生物膜的形成具有抑制作用:该研究证明了氧化应激诱导剂(如次黄嘌呤和天门冬氨酸代谢途径)在粪大肠杆菌生物膜形成中的重要性。针对这些代谢标记物的靶向疗法可以减轻与粪大肠杆菌感染相关的医疗负担。
Targeted metabolomics analysis approach to unravel the biofilm formation pathways of Enterococcus faecalis clinical isolates
Aim
(i) To characterize Enterococcus faecalis biofilm formation pathways by semi-targeted metabolomics and targeted nitrogen panel analysis of strong (Ef63) and weak (Ef 64) biofilm forming E. faecalis clinical isolates and (ii) to validate the identified metabolic markers using targeted inhibitors.
Methodology
Previous proteomics profiling of E. faecalis clinical isolates with strong and weak biofilm formation revealed that differences in metabolic activity levels of small molecule, nucleotide and nitrogen compound metabolic processes and biosynthetic pathways, cofactor metabolic process, cellular amino acid and derivative metabolic process and lyase activity were associated with differences in biofilm formation. Hence, semi-targeted analysis of Ef 63, Ef 64 and ATC control strain Ef 29212 was performed by selecting metabolites that were part of both the previously identified pathways and a curated library with confirmed physical and chemical identity, followed by confirmatory targeted nitrogen panel analysis. Significantly regulated metabolites (p < .05) were selected based on fold change cut-offs of 1.2 and 0.8 for upregulation and downregulation, respectively, and subjected to pathway enrichment analysis. The identified metabolites and pathways were validated by minimum biofilm inhibitory concentration (MBIC) and colony forming unit (CFU) assays with targeted inhibitors.
Results
Metabolomics analysis showed upregulation of betaine, hypoxanthine, glycerophosphorylcholine, tyrosine, inosine, allantoin and citrulline in Ef 63 w.r.t Ef 64 and Ef 29212, and thesemetabolites mapped to purinemetabolism, urea cycle and aspartate metabolism pathways. MBIC and CFU assays using compounds against selected metabolites and metabolic pathways, namely glutathione against hypoxanthine and hydroxylamine against aspartate metabolism showed inhibitory effects against E. faecalis biofilm formation.
Conclusions
The study demonstrated the importance of oxidative stress inducers such as hypoxanthine and aspartate metabolism pathway in E. faecalis biofilm formation. Targeted therapeutics against these metabolic markers can reduce the healthcare burden associated with E. faecalis infections.
期刊介绍:
The International Endodontic Journal is published monthly and strives to publish original articles of the highest quality to disseminate scientific and clinical knowledge; all manuscripts are subjected to peer review. Original scientific articles are published in the areas of biomedical science, applied materials science, bioengineering, epidemiology and social science relevant to endodontic disease and its management, and to the restoration of root-treated teeth. In addition, review articles, reports of clinical cases, book reviews, summaries and abstracts of scientific meetings and news items are accepted.
The International Endodontic Journal is essential reading for general dental practitioners, specialist endodontists, research, scientists and dental teachers.